UBS Group’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Sell |
173,132
-108,825
| -39% | -$141K | ﹤0.01% | 5411 |
|
|
2025
Q1 | $392K | Buy |
281,957
+196,788
| +231% | +$274K | ﹤0.01% | 4846 |
|
|
2024
Q4 | $195K | Buy |
85,169
+78,125
| +1,109% | +$179K | ﹤0.01% | 5267 |
|
|
2024
Q3 | $19.2K | Sell |
7,044
-1,118
| -14% | -$3.04K | ﹤0.01% | 6194 |
|
|
2024
Q2 | $19.1K | Sell |
8,162
-13,287
| -62% | -$31.1K | ﹤0.01% | 6181 |
|
|
2024
Q1 | $101K | Sell |
21,449
-3,948
| -16% | -$18.5K | ﹤0.01% | 5068 |
|
|
2023
Q4 | $124K | Buy |
25,397
+15,289
| +151% | +$74.6K | ﹤0.01% | 4868 |
|
|
2023
Q3 | $47K | Buy |
10,108
+664
| +7% | +$3.09K | ﹤0.01% | 5198 |
|
|
2023
Q2 | $69.8K | Buy |
9,444
+5,286
| +127% | +$39.1K | ﹤0.01% | 5219 |
|
|
2023
Q1 | $34K | Buy |
4,158
+2,527
| +155% | +$20.7K | ﹤0.01% | 5624 |
|
|
2022
Q4 | $15.6K | Buy |
+1,631
| New | +$15.6K | ﹤0.01% | 6781 |
|
|
2022
Q3 | – | Sell |
-844
| Closed | -$11K | – | 9169 |
|
|
2022
Q2 | $11K | Sell |
844
-899
| -52% | -$11.7K | ﹤0.01% | 6740 |
|
|
2022
Q1 | $19K | Sell |
1,743
-866
| -33% | -$9.44K | ﹤0.01% | 6454 |
|
|
2021
Q4 | $40K | Buy |
2,609
+609
| +30% | +$9.34K | ﹤0.01% | 6008 |
|
|
2021
Q3 | $28K | Buy |
2,000
+1,777
| +797% | +$24.9K | ﹤0.01% | 5683 |
|
|
2021
Q2 | $4K | Buy |
+223
| New | +$4K | ﹤0.01% | 7540 |
|